Key statistics
As of last trade AngioDynamics Inc (UG2:FRA) traded at 6.55, -10.88% below its 52-week high of 7.35, set on Jan 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.55 |
---|---|
High | 6.55 |
Low | 6.55 |
Bid | 6.30 |
Offer | 6.90 |
Previous close | 6.30 |
Average volume | 79.56 |
---|---|
Shares outstanding | 40.63m |
Free float | 38.41m |
P/E (TTM) | -- |
Market cap | 282.41m USD |
EPS (TTM) | -6.04 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 07:05 GMT.
More ▼
Press releases
- AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System
- AngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver
- AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results
- AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes
- AngioDynamics to Report Fiscal 2025 First Quarter Financial Results on October 3, 2024
- AngioDynamics Announces CE Mark Approval in Europe for the Auryon System
More ▼